| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA993251 | F | Cytotoxicity against human DoTc24510 cells expressing wild type EGFR at 200 nM assessed as fraction of viable cells after 72 hrs relative to control | Homo sapiens | 1 | ALA1149823 | cell-based format | Scientific Literature | |
| 2. | ALA2363194 | F | SANGER: Inhibition of human DoTc2-4510 cell growth in a cell viability assay. | Homo sapiens | 98 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
| 3. | ALA3429606 | F | Cytotoxicity against human DoTc2-4510 cells carrying BRCA2 mutant assessed as inhibition of cell proliferation after 5 to 7 days by CellTiter-Blue assay | Homo sapiens | 1 | ALA3425485 | cell-based format | Scientific Literature | |
| 4. | ALA4012933 | F | Growth inhibition of human DoTc2-4510 cells harboring Wnt or BRCA1/2 mutant after 6 days in presence of 1% FBS by Cell-Titer Glo assay | Homo sapiens | 1 | ALA4011625 | cell-based format | Scientific Literature | |
| 5. | ALA4012962 | F | Growth inhibition of human DoTc2-4510 cells harboring Wnt or BRCA1/2 mutant at 10 uM after 6 days in presence of 1% FBS by Cell-Titer Glo assay relative to control | Homo sapiens | 1 | ALA4011625 | cell-based format | Scientific Literature | |
| 6. | ALA4012985 | F | Growth inhibition of human DoTc2-4510 cells harboring Wnt or BRCA1/2 mutant after 6 days in presence of 10% FBS by Cell-Titer Glo assay | Homo sapiens | 1 | ALA4011625 | cell-based format | Scientific Literature | |
| 7. | ALA4013013 | F | Growth inhibition of human DoTc2-4510 cells harboring Wnt or BRCA1/2 mutant at 10 uM after 6 days in presence of 10% FBS by Cell-Titer Glo assay relative to control | Homo sapiens | 1 | ALA4011625 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!